XML 40 R29.htm IDEA: XBRL DOCUMENT v2.4.1.9
Related Parties and Related Party Transactions (Tables)
12 Months Ended
Dec. 31, 2014
Astellas [Member]  
Revenue from Related Party

Research and development revenue from Astellas was as follows (in thousands):

 

     Year Ended
December 31,
2014
     Year Ended
December 31,
2013
 

Research and development revenues with related parties:

     

Research and development milestone fees

   $ 15,000           

Research and development revenues:

     

Reimbursement of internal costs

     8,939         3,285   

Reimbursement of other costs

     6,452         3,130   

Research and development milestone fees

     2,000           
  

 

 

    

 

 

 

Total research and development revenue from Astellas

   $ 32,391       $ 6,415   
  

 

 

    

 

 

 
Amgen [Member]  
Revenue from Related Party

Revenue from Amgen was as follows (in thousands):

 

     Years Ended December 31,  
     2014      2013      2012  

License revenues from related parties

   $       $ 17,230       $   

Research and development revenues from related parties:

        

Reimbursement of internal costs

     4,260         2,019         4,174   

Reimbursement of other costs

                     3   

Allocated consideration

     278                   
  

 

 

    

 

 

    

 

 

 

Total revenues from Amgen

   $ 4,538       $ 19,249       $ 4,177